Financhill
Sell
43

TAK Quote, Financials, Valuation and Earnings

Last price:
$15.20
Seasonality move :
3.15%
Day range:
$15.18 - $15.33
52-week range:
$12.58 - $15.43
Dividend yield:
4.07%
P/E ratio:
69.66x
P/S ratio:
1.63x
P/B ratio:
1.02x
Volume:
2.4M
Avg. volume:
2.1M
1-year change:
16.21%
Market cap:
$47.5B
Revenue:
$30.1B
EPS (TTM):
$0.22

Earnings Data

Next earnings date for TAK
Oct 31
2025
Most recent earnings per share
-$0.21
Missed by $0.21
(May 8/2025)
Consensus Estimate
--
(May 8/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TAK Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $8B -- -- -- --
05/08/2025 Q1 $7.6B $6.9B -$0.21 -- --
01/30/2025 Q4 $7.3B $7.5B $0.05 -- --
10/31/2024 Q3 $7.2B $7.9B $0.19 -- --
07/31/2024 Q2 $6.8B $7.7B $0.19 -- --
05/09/2024 Q1 $5.8B $7.1B -$0.01 -- --
02/01/2024 Q4 $6.8B $7.5B $0.23 -- --
10/26/2023 Q3 -- -- -$0.11 -- --
07/27/2023 Q2 -- -- $0.21 -- --
05/11/2023 Q1 -- -- $0.07 -- --
02/02/2023 Q4 -- -- $0.27 -- --
10/27/2022 Q3 -- -- $0.14 -- --
07/28/2022 Q2 -- -- $0.26 -- --
05/11/2022 Q1 -- -- -$0.03 -- --
02/03/2022 Q4 -- -- $0.16 -- --
10/28/2021 Q3 -- -- $0.13 -- --
07/30/2021 Q2 -- -- $0.40 -- --
05/11/2021 Q1 -- -- $0.59 -- --
02/04/2021 Q4 -- -- $0.28 -- --
10/29/2020 Q3 -- -- $0.01 -- --
07/31/2020 Q2 -- -- $0.24 -- --
03/31/2020 Q1 -- -- $0.00 -- --
12/31/2019 Q4 -- -- -$0.10 -- --
09/30/2019 Q3 -- -- $0.16 -- --

Takeda Pharmaceutical Earnings Questions

  • How Much did Takeda Pharmaceutical Generate in Revenue Last Quarter?

    Takeda Pharmaceutical reported $6.9B worth of top line sales in its most recent quarter.

  • Did Takeda Pharmaceutical Beat Earnings Last Quarter?

    Takeda Pharmaceutical announced earnings per share of -$0.21 which represents a miss of analyst forecast a -- per share.

  • Is Takeda Pharmaceutical Profitable?

    Takeda Pharmaceutical reported $4.4B that represents $1.35 per share over the last quarter.

  • What is the Analyst Consensus for Takeda Pharmaceutical EPS Next Year?

    Takeda Pharmaceutical's earnings are forecast to grow from $0.22 per share to -- per share next year representing an increase of --.

  • When is Takeda Pharmaceutical's Earnings Date?

    Takeda Pharmaceutical's next earnings date is October 31, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will AST SpaceMobile Be In 5 Years?
Where Will AST SpaceMobile Be In 5 Years?

Ever tried to send a text from the Nevada desert…

Is TTD The Big Winner If Pharma Ads Are Banned?
Is TTD The Big Winner If Pharma Ads Are Banned?

Last week, Senators Bernie Sanders and Angus King introduced a…

Is Palantir Stock Overvalued?
Is Palantir Stock Overvalued?

By every traditional yardstick, including a price‑to‑sales well above 100,…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 48x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Sell
11
VEON alert for Jun 14

VEON [VEON] is down 18.57% over the past day.

Buy
74
DAVE alert for Jun 14

Dave [DAVE] is down 12.68% over the past day.

Buy
54
DAR alert for Jun 14

Darling Ingredients [DAR] is up 9.12% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock